Transcriptional expression patterns triggered by chemically distinct neuroprotective molecules

Neuroscience

Volumn 226, Issue , 2012, Pages 10-20

  Pappas, D J ^a   Gabatto, P A ^a   Oksenberg, D ^a   Khankhanian, P ^a   Baranzini, S E ^a   Gan, L ^b   Oksenberg, J R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Excitotoxicity; Glutamate; Microarray; Neuron; Neuroprotection; NMDA

Indexed keywords

AGMATINE; BACLOFEN; BENZAMIDE; CALCIUM ION; CARBENOXOLONE; CITICOLINE; CYCLOPHOSPHAMIDE; DIZOCILPINE; FLECAINIDE; GLUTAMATE RECEPTOR; HYPOXIA INDUCIBLE FACTOR; IFENPRODIL; INDOMETACIN; INTERFERON; INTERFERON REGULATORY FACTOR 7; ION CHANNEL; LATAMOXEF; LIOTHYRONINE; MEMANTINE; METHOTREXATE; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID; NECROSTATIN 1; NEUROPROTECTIVE AGENT; RESVERATROL; RILUZOLE; RNA; ROLIPRAM; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ARTICLE; BRAIN CELL; CALCIUM TRANSPORT; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; EXCITOTOXICITY; EXPOSURE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; INTERFERON REGULATORY FACTOR 7 GENE; MICROARRAY ANALYSIS; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA ISOLATION;

ANIMALS; CALCIUM; CELL ADHESION; CELL SURVIVAL; CEREBRAL CORTEX; DATA MINING; GENE LIBRARY; GENOME-WIDE ASSOCIATION STUDY; GLUTAMIC ACID; HYPOXIA-INDUCIBLE FACTOR 1; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; NEUROPROTECTIVE AGENTS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, N-METHYL-D-ASPARTATE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

EID: 84867319871     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.09.007     Document Type: Article

References (53)

1. Abell A.N., Johnson G.L. MEKK4 is an effector of the embryonic TRAF4 for JNK activation. J Biol Chem 2005, 280:35793-35796.
2. Assenov Y., Ramirez F., Schelhorn S.E., Lengauer T., Albrecht M. Computing topological parameters of biological networks. Bioinformatics 2008, 24:282-284.
3. Baranzini S.E., Srinivasan R., Khankhanian P., Okuda D.T., Nelson S.J., Matthews P.M., Hauser S.L., Oksenberg J.R., Pelletier D. Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain 2010, 133:2603-2611.
4. Barrett T., Troup D.B., Wilhite S.E., Ledoux P., Evangelista C., Kim I.F., Tomashevsky M., Marshall K.A., Phillippy K.H., Sherman P.M., Muertter R.N., Holko M., Ayanbule O., Yefanov A., Soboleva A. NCBI GEO: archive for functional genomics data sets - 10 years on. Nucleic Acids Res 2011, 39:D1005-D1010.
5. Besancon E., Guo S., Lok J., Tymianski M., Lo E.H. Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci 2008, 29:268-275.
6. Blake J.A., Bult C.J., Kadin J.A., Richardson J.E., Eppig J.T. The Mouse Genome Database (MGD): premier model organism resource for mammalian genomics and genetics. Nucleic Acids Res 2010, 39:D842-D848.
7. Bolton C., Paul C. Glutamate receptors in neuroinflammatory demyelinating disease. Mediators Inflamm 2006, 2006:93684.
8. Centeno C., Repici M., Chatton J.Y., Riederer B.M., Bonny C., Nicod P., Price M., Clarke P.G., Papa S., Franzoso G., Borsello T. Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons. Cell Death Differ 2007, 14:240-253.
9. Chalifa-Caspi V., Yanai I., Ophir R., Rosen N., Shmoish M., Benjamin-Rodrig H., Shklar M., Stein T.I., Shmueli O., Safran M., Lancet D. GeneAnnot: comprehensive two-way linking between oligonucleotide array probesets and GeneCards genes. Bioinformatics 2004, 20:1457-1458.
10. Chen J., Zhou Y., Mueller-Steiner S., Chen L.F., Kwon H., Yi S., Mucke L., Gan L. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 2005, 280:40364-40374.
11. Connell B.J., Crosby K.M., Richard M.J., Mayne M.B., Saleh T.M. Estrogen-mediated neuroprotection in the cortex may require NMDA receptor activation. Neuroscience 2007, 146:160-169.
12. Dong X.X., Wang Y., Qin Z.H. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin 2009, 30:379-387.
13. Ejima K., Nanri H., Araki M., Uchida K., Kashimura M., Ikeda M. 17Beta-estradiol induces protein thiol/disulfide oxidoreductases and protects cultured bovine aortic endothelial cells from oxidative stress. Eur J Endocrinol 1999, 140:608-613.
14. Gidday J.M. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 2006, 7:437-448.
15. Gidday J.M. Pharmacologic preconditioning: translating the promise. Transl Stroke Res 2010, 1:19-30.
16. Hara T., Hamada J., Yano S., Morioka M., Kai Y., Ushio Y. CREB is required for acquisition of ischemic tolerance in gerbil hippocampal CA1 region. J Neurochem 2003, 86:805-814.
17. Hardingham G.E. Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem Soc Trans 2009, 37:1147-1160.
18. Hardingham G.E., Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 2010, 11:682-696.
19. Hindorff L.A., Sethupathy P., Junkins H.A., Ramos E.M., Mehta J.P., Collins F.S., Manolio T.A. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009, 106:9362-9367.
20. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434:772-777.
21. Hoyte L., Barber P.A., Buchan A.M., Hill M.D. The rise and fall of NMDA antagonists for ischemic stroke. Curr Mol Med 2004, 4:131-136.
22. Jin R.L., Li W.B., Li Q.J., Zhang M., Xian X.H., Sun X.C., Zhao H.G., Qi J. The role of extracellular signal-regulated kinases in the neuroprotection of limb ischemic preconditioning. Neurosci Res 2006, 55:65-73.
23. Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., Haussler D. The human genome browser at UCSC. Genome Res 2002, 12:996-1006.
24. Lau A., Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 2010, 460:525-542.
25. Liu X.Q., Sheng R., Qin Z.H. The neuroprotective mechanism of brain ischemic preconditioning. Acta Pharmacol Sin 2009, 30:1071-1080.
26. Marsh B., Stevens S.L., Packard A.E., Gopalan B., Hunter B., Leung P.Y., Harrington C.A., Stenzel-Poore M.P. Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: critical role for IRF3. J Neurosci 2009, 29:9839-9849.
27. Mathie A., Veale E.L. Therapeutic potential of neuronal two-pore domain potassium-channel modulators. Curr Opin Investig Drugs 2007, 8:555-562.
28. Ousman S.S., Wang J., Campbell I.L. Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J Virol 2005, 79:7514-7527.
29. Panne D. The enhanceosome. Curr Opin Struct Biol 2008, 18:236-242.
30. Peri S., Navarro J.D., Amanchy R., Kristiansen T.Z., Jonnalagadda C.K., Surendranath V., Niranjan V., Muthusamy B., Gandhi T.K., Gronborg M., Ibarrola N., Deshpande N., Shanker K., Shivashankar H.N., Rashmi B.P., Ramya M.A., Zhao Z., Chandrika K.N., Padma N., Harsha H.C., Yatish A.J., Kavitha M.P., Menezes M., Choudhury D.R., Suresh S., Ghosh N., Saravana R., Chandran S., Krishna S., Joy M., Anand S.K., Madavan V., Joseph A., Wong G.W., Schiemann W.P., Constantinescu S.N., Huang L., Khosravi-Far R., Steen H., Tewari M., Ghaffari S., Blobe G.C., Dang C.V., Garcia J.G., Pevsner J., Jensen O.N., Roepstorff P., Deshpande K.S., Chinnaiyan A.M., Hamosh A., Chakravarti A., Pandey A. Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res 2003, 13:2363-2371.
31. Qi S.H., Liu Y., Hao L.Y., Guan Q.H., Gu Y.H., Zhang J., Yan H., Wang M., Zhang G.Y. Neuroprotection of ethanol against ischemia/reperfusion-induced brain injury through decreasing c-Jun N-terminal kinase 3 (JNK3) activation by enhancing GABA release. Neuroscience 2010, 167:1125-1137.
32. Romera C., Hurtado O., Botella S.H., Lizasoain I., Cardenas A., Fernandez-Tome P., Leza J.C., Lorenzo P., Moro M.A. In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor-alpha pathway. J Neurosci 2004, 24:1350-1357.
33. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34:374-378.
34. Saleh M.C., Connell B.J., Saleh T.M. Resveratrol preconditioning induces cellular stress proteins and is mediated via NMDA and estrogen receptors. Neuroscience 2009, 166:445-454.
35. Savitsky D., Tamura T., Yanai H., Taniguchi T. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol Immunother 2010, 59:489-510.
36. Sawe N., Steinberg G., Zhao H. Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J Neurosci Res 2008, 86:1659-1669.
37. Schmidt H., Raasch J., Merkler D., Klinker F., Krauss S., Bruck W., Prinz M. Type I interferon receptor signalling is induced during demyelination while its function for myelin damage and repair is redundant. Exp Neurol 2009, 216:306-311.
38. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13:2498-2504.
39. Sheldon A.L., Robinson M.B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int 2007, 51:333-355.
40. Song J.H., Huang C.S., Nagata K., Yeh J.Z., Narahashi T. Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels. J Pharmacol Exp Ther 1997, 282:707-714.
41. Stevens S.L., Leung P.Y., Vartanian K.B., Gopalan B., Yang T., Simon R.P., Stenzel-Poore M.P. Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury. J Neurosci 2011, 31:8456-8463.
42. Takeshita F., Ishii K.J., Kobiyama K., Kojima Y., Coban C., Sasaki S., Ishii N., Klinman D.M., Okuda K., Akira S., Suzuki K. TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF. Eur J Immunol 2005, 35:2477-2485.
43. Terasaki Y., Sasaki T., Yagita Y., Okazaki S., Sugiyama Y., Oyama N., Omura-Matsuoka E., Sakoda S., Kitagawa K. Activation of NR2A receptors induces ischemic tolerance through CREB signaling. J Cereb Blood Flow Metab 2010, 30:1441-1449.
44. Trapp B.D., Stys P.K. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 2009, 8:280-291.
45. Vadigepalli R., Chakravarthula P., Zak D.E., Schwaber J.S., Gonye G.E. PAINT: a promoter analysis and interaction network generation tool for gene regulatory network identification. OMICS 2003, 7:235-252.
46. Villmann C., Becker C.M. On the hypes and falls in neuroprotection: targeting the NMDA receptor. Neuroscientist 2007, 13:594-615.
47. Wang L., Khankhanian P., Baranzini S.E., Mousavi P. iCTNet: a Cytoscape plugin to produce and analyze integrative complex traits networks. BMC Bioinformatics 2011, 12:380.
48. Wang R.M., Zhang Q.G., Li J., Yang L.C., Yang F., Brann D.W. The ERK5-MEF2C transcription factor pathway contributes to anti-apoptotic effect of cerebral ischemia preconditioning in the hippocampal CA1 region of rats. Brain Res 2009, 1255:32-41.
49. Wang Y.C., Lin S., Yang Q.W. Toll-like receptors in cerebral ischemic inflammatory injury. J Neuroinflammation 2011, 8:134.
50. Wishart D.S., Knox C., Guo A.C., Cheng D., Shrivastava S., Tzur D., Gautam B., Hassanali M. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 2008, 36:D901-D906.
51. Yamasaki T., Kawasaki H., Nishina H. Diverse roles of JNK and MKK pathways in the brain. J Signal Transduct 2012, 2012:459265.
52. Zhang B., Kirov S., Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 2005, 33:W741-W748.
53. Zhang Q.G., Wang R.M., Han D., Yang L.C., Li J., Brann D.W. Preconditioning neuroprotection in global cerebral ischemia involves NMDA receptor-mediated ERK-JNK3 crosstalk. Neurosci Res 2009, 63:205-212.